Man Group PLC Pyxis Oncology, Inc. Call Options Transaction History
Man Group PLC
- $36 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PYXS
# of Institutions
92Shares Held
29.4MCall Options Held
134KPut Options Held
5K-
Deep Track Capital, LP Greenwich, CT4.18MShares$17.9 Million0.57% of portfolio
-
Laurion Capital Management LP New York, NY3.86MShares$16.5 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$11.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$10.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.34MShares$5.72 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $150M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...